Chemotherapy for small cell lung cancer: a comprehensive review

Chemotherapy for small cell lung cancer: a comprehensive review

Combination chemotherapy is the current strategy of choice for treatment of small cell lung cancer (SCLC). Platinum containing combination regimens are superior to non-platinum regimens in limited stage- SCLC and possibly also in extensive stage-SCLC as first and second-line treatments. The addition...

Full description

Bibliographic Details
Main Authors:	Syed Mustafa Karim, Jamal Zekri
Format:	Article
Language:	English
Published:	PAGEPress Publications 2012-04-01
Series:	Oncology Reviews
Subjects:	small cell lung cancer SCLC chemotherapy cisplatin carboplatin etoposide
Online Access:	http://www.oncologyreviews.org/index.php/or/article/view/162

Similar Items

A Retrospective Cohort Study on Pretreated Neutrophil-to-Lymphocyte Ratio and Prognosis of Small Cell Lung Cancer: Evidence of Effect Modification by Chemotherapy Regimen
by: Liu F, et al.
Published: (2020-10-01)

Cisplatin, Etoposide, and Vincristine Combination Chemotherapy in the Treatment of Non-Small Cell Lung Cancer
by: SAITO, HIDEHIKO, et al.
Published: (1993)

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer
by: Thierry Berghmans, et al.
Published: (2017-09-01)

Chemotherapy plus atezolizumab for a patient with small cell lung cancer undergoing haemodialysis: a case report and review of literature
by: Mihoko Imaji, et al.
Published: (2021-05-01)

Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer
by: Nobutaka Kataoka, et al.
Published: (2020-09-01)

Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011-12-01)

Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011-12-01)

Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma
by: Valiollah Mehrzad, et al.
Published: (2017-01-01)

Successful treatment of limited-stage small-cell lung cancer in the right mainstem bronchus by a combination of chemotherapy and argon plasma coagulation
by: Takayuki Takeda, et al.
Published: (2017-01-01)

A Randomized Controlled Study of Chemotherapy:  Etoposide Combined with Oxaliplatin or Cisplatin Regimens in the Treatment  of Extensive-stage Small Cell Lung Cancer in Elderly Patients
by: Dan PU, et al.
Published: (2013-01-01)

Febrile neutropenia in chemotherapy treated small-cell lung cancer patients
by: Kukec Renata Rezonja, et al.
Published: (2015-06-01)

Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy
by: Hsing-Wei Hung, et al.
Published: (2021-05-01)

A case report of advanced gastric small cell carcinoma with neoadjuvant chemotherapy followed by radical total gastrectomy
by: Bing Wang, et al.
Published: (2020-12-01)

Neoadjuvant chemotherapy in the setting of locally advanced olfactory neuroblastoma with intracranial extension
by: Raid Aljumaily, et al.
Published: (2011-01-01)

Prognostic value of chemotherapy-induced leukopenia in small-cell lung cancer
by: Wei Liu, et al.
Published: (2013-06-01)

Irinotecan/cisplatin versus Etoposide/cisplatin for Patients with Extensive Stage Small Cell Lung Cancer: A Systematic Review
by: Nan YAO, et al.
Published: (2009-08-01)

Poorly Differentiated Small-Cell-Type Neuroendocrine Carcinoma of the Prostate: A Case Report and Literature Review
by: Kishore Kumar, et al.
Published: (2018-10-01)

Primary Small Cell Carcinoma of the Tonsil: A Case Report and Review of the Literature
by: Amikar Sehdev, et al.
Published: (2012-10-01)

Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
by: Yayi He, et al.
Published: (2021-02-01)

A Prospective Randomized Study of Adjuvant Chemotherapy in Resected Stage IIIA-N2 Non-small Cell Lung Cancer
by: Haibo SUN, et al.
Published: (2009-09-01)

Comparison of Chemotherapy Regiments between Cisplatin Etoposide and Cisplatin-Docetaxel on 2-Year and Progression-Free Survival in Late-Stage Non-Small Cell Lung Cancer Patients
by: Salman Paris Harahap, et al.
Published: (2016-06-01)

Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report
by: Alexandra Sokolova, et al.
Published: (2017-04-01)

Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study
by: Shinogu Takashima, et al.
Published: (2020-10-01)

Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604
by: Yuki Misumi, et al.
Published: (2017-05-01)

Long-Lasting Complete Remission of Small-Cell Carcinoma of the Pancreas with Carboplatin and Etoposide Complicated by Gallbladder Adenocarcinoma Diagnosed during Follow-Up
by: Konstantinos Tyriakidis, et al.
Published: (2021-03-01)

The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis
by: Olga Caramelo, et al.
Published: (2019-03-01)

Cost-effectiveness analysis of paclitaxel + carboplatin vs. alternative combinations in the treatment of non-small cell lung cancer
by: Mario Eandi
Published: (2006-09-01)

Cisplatin-based Chemotherapy in Elderly Patients with Non-small Cell Lung Cancer
by: Jian Li, et al.
Published: (2010-03-01)

A Meta-Analysis of Platinum Plus Gemcitabine or Vinorelbine for Advanced Non-small Cell Lung Cancer
by: Guanghui GAO, et al.
Published: (2009-01-01)

Maintenance therapy with oral etoposide following first-line docetaxel-cisplatin chemotherapy in metastatic non-small cell lung cancer patients
by: Meiyu Fang, et al.
Published: (2012-09-01)

Immunotherapy in Small Cell Lung Cancer
by: Antonio Rossi
Published: (2019-06-01)

Pemetrexed Combined with Cisplatin or Carboplatin Regimen in the Treatment of Advanced Recurrent or Metastasis Non-small Cell Lung Cancer: Analysis of 63 Cases
by: Wei WANG, et al.
Published: (2011-01-01)

A pilot study of adjuvant chemotherapy with carboplatin and oral S‐1 for patients with completely resected stage II to IIIA non‐small cell lung cancer
by: Hisashi Tanaka, et al.
Published: (2020-06-01)

Pharmacoeconomic benefit of cisplatin and etoposide chemoregimen for metastatic non small cell lung cancer: An Indian study
by: Mangesh P Kamath, et al.
Published: (2016-01-01)

Early Onset of Platinum Hypersensitivity in a Dentist:A Case Report
by: Maurie Markman, et al.
Published: (2010-08-01)

Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre
by: Sue Cheeseman, et al.
Published: (2020-02-01)

Combination of cyclophosphamide, etoposide, carboplatin and dexamethasone as a salvage regimen for refractory multiple myeloma patients: a comparison with a historical control group
by: Reza Safaee, et al.
Published: (2012-07-01)

POLYSACCHARIDES TUSSILAGOFARFARA L. REDUCE MYELOSUPPRESSION INDUCED BY CISPLATIN AND ETOPOSIDE
by: E. A. Safonova, et al.
Published: (2017-09-01)

Evaluation du suivi thérapeutique pharmacologique du carboplatine et étude pharmacocinétique-pharmacogénétique de l'étoposide dans le cadre d'un essai clinique de phase II d'intensification thérapeutique en cancérologie
by: Moeung, Sotheara
Published: (2018)

Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin
by: Kauffmann-Guerrero D, et al.
Published: (2020-03-01)